---
title: New Report Highlights Risks of U.S. Drug Reimportation
description: Joint Oncologie and Merck Phase II Trial Announced for Gastric and Gastroesophageal Cancers
---

[News ](https://www.yourway.com/news)

# [New Report Highlights Risks of U.S. Drug Reimportation](https://www.yourway.com/news/joint-oncologie-and-merck-phase-ii-trial-announced-for-gastric-and-gastroesophageal-cancers)

 Written by [Yourway](https://www.yourway.com/news/author/yourway) | September 9, 2019

Oncologie and Merck will launch a [phase II trial](https://www.biospace.com/article/releases/oncologie-inc-announces-clinical-trial-collaboration-with-merck-to-evaluate-bavituximab-in-combination-with-keytruda-pembrolizumab-in-advanced-gastric-or-gastroesophageal-cancer/) to investigate Merck’s Keytruda (pembrolizumab) and Oncologie’s bavituximab, an antibody that blocks the activity of phosphatidylserine (PS) in advanced gastric or gastroesophageal cancer. International trials like this one — enrolling patients in the United States, the UK, Korea, and Taiwan — are a particular specialty at Yourway.

[View full post](https://www.yourway.com/news/joint-oncologie-and-merck-phase-ii-trial-announced-for-gastric-and-gastroesophageal-cancers)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Yourway"
  },
  "dateModified" : "2019-09-09T13:44:39.974Z",
  "datePublished" : "2019-09-09T13:44:39Z",
  "headline" : "New Report Highlights Risks of U.S. Drug Reimportation",
  "image" : {
    "@type" : "ImageObject",
    "height" : 685,
    "url" : "https://cdn2.hubspot.net/hubfs/5402331/News%20and%20Articles%20Banners/Media_News_090919.jpg",
    "width" : 1440
  },
  "mainEntityOfPage" : "https://www.yourway.com/news/joint-oncologie-and-merck-phase-ii-trial-announced-for-gastric-and-gastroesophageal-cancers",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "News"
  }
}
```